Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country.
This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.
Clinical study results Sanofi pharma, including Sanofi Genzyme – Letter T
GENERIC NAME |
TRADE NAME |
CONDITION |
STUDY CODE |
STUDY NAME |
ACCESS TO STUDY / PROTOCOL |
ACCESS TO RESULTS |
---|---|---|---|---|---|---|
TEICOPLANIN |
Targocid |
Infection |
M000507_6004 |
TARGO-FEN |
||
TELITHROMYCIN |
Ketek |
Otitis Media, Acute |
EFC6131 (HMR 3647A/3001) |
NA |
||
TELITHROMYCIN |
Ketek |
Acute otitis media |
EFC6132 |
TELI COM |
||
TELITHROMYCIN |
Ketek |
Tonsillitis, Pharyngitis |
EFC6133 |
TELI TON |
||
TELITHROMYCIN |
Ketek |
Tonsillitis, Pharyngitis |
EFC6134 |
TELI TAD |
||
TELITHROMYCIN |
Ketek |
Pneumonia, Community-Acquired |
EFC6369 (HMR 3647B/3101) |
NA |
||
TELITHROMYCIN |
Ketek |
Otitis Media, Acute |
EFC6370 (HMR 3647B/3103) |
NA |
||
TELITHROMYCIN |
Ketek |
Infection |
EFC6371 (HMR 3647B/3104) |
NA |
||
TELITHROMYCIN |
Ketek |
Asthma |
HMR3647A_3503 |
TELICAST |
||
TELITHROMYCIN |
Ketek |
Infection |
HMR3647A_4014 |
STROBE |
||
TELITHROMYCIN |
Ketek |
Infection |
HMR3647A_4015 |
COBRA |
||
TELITHROMYCIN |
Ketek |
Infection |
HMR3647A_4017 |
NA |
||
TELITHROMYCIN |
Ketek |
Infection |
HMR3647A_4018 |
NA |
||
TELITHROMYCIN |
Ketek |
Infection |
HMR3647A_4019 |
KEYS |
||
TELITHROMYCIN |
Ketek |
Infection |
HMR3647A_4020 |
PERSPECTIVE |
||
TELITHROMYCIN |
Ketek |
Infection |
HMR3647A_4022 |
SCOPE |
||
TELITHROMYCIN |
Ketek |
Sinusitis, Acute Bacterial |
HMR3647A_4023 |
CHOOSE |
||
TELITHROMYCIN |
Ketek |
Infection |
HMR3647A_4026 |
NA |
||
TELITHROMYCIN |
Ketek |
Infection |
HMR3647A_4027 |
COBRA II |
||
Teriflunomide |
Aubagio |
Multiple Sclerosis |
BDR16019 |
TERI-PK |
||
TERIFLUNOMIDE |
Aubagio |
Multiple Sclerosis |
HMR11726D/2001 |
NA |
||
TERIFLUNOMIDE |
Aubagio |
Multiple Sclerosis |
EFC6049 |
TEMSO |
||
TERIFLUNOMIDE |
Aubagio |
Multiple Sclerosis |
PDY6046 |
NA |
||
TERIFLUNOMIDE |
Aubagio |
Multiple Sclerosis |
PDY6045 |
NA |
||
TERIFLUNOMIDE |
Aubagio |
Multiple Sclerosis |
LTS6047 |
NA |
||
TERIFLUNOMIDE |
Aubagio |
Multiple Sclerosis |
EFC10891 |
TENERE |
||
TERIFLUNOMIDE |
Aubagio |
Multiple Sclerosis |
PDY11684 |
TERIVA |
||
TERIFLUNOMIDE |
Aubagio |
Multiple Sclerosis |
POP11432 |
NA |
||
TERIFLUNOMIDE |
Aubagio |
Multiple Sclerosis |
EFC10531 |
TOWER |
||
TERIFLUNOMIDE |
Aubagio |
Multiple Sclerosis |
EFC6058 |
TERACLES |
||
TERIFLUNOMIDE |
Aubagio |
Multiple Sclerosis |
EFC6260 |
TOPIC |
||
TERIFLUNOMIDE |
Aubagio |
Multiple Sclerosis |
LPS13539 |
TERIDYNAMIC |
||
TERIFLUNOMIDE |
Aubagio |
Multiple Sclerosis |
PKM12788 |
NA |
||
TERIFLUNOMIDE |
Aubagio |
Multiple Sclerosis |
LTS6048 |
NA |
||
TERIFLUNOMIDE |
Aubagio |
Multiple Sclerosis |
LPS13567 |
TERI-PRO |
||
TERIFLUNOMIDE |
Aubagio |
Multiple Sclerosis |
LTS6050 |
NA |
||
THIOCOLCHICOSIDE |
Muscoril, Myoril |
Pain |
L_9826 |
MYLOBAC |
||
THIOCOLCHICOSIDE |
Muscoril, Myoril |
Pain |
L_9892 |
EMINEM |
||
THIOCOLCHICOSIDE+ KETOPROFEN |
Muscoril Plus |
Pain |
KETOP_R_02693 |
TIOKET |
||
THYROTROPIN ALFA |
Thyrogen |
Diagnostic Tool for Thyroglobulin Testing |
THYR00700* |
|
|
|
THYROTROPIN ALFA |
Thyrogen |
Diagnostic Tool for Thyroglobulin Testing |
THYR00800* |
|
||
THYROTROPIN ALFA |
Thyrogen |
Diagnostic Tool for Thyroglobulin Testing |
THYR01605 |
NA |
||
THYROTROPIN ALFA |
Thyrogen |
Diagnostic for Detection of Thyroid Cancer |
TSH92-0601* |
|
|
|
THYROTROPIN ALFA |
Thyrogen |
Thyroid Cancer |
TSH94-0301* |
|
|
|
THYROTROPIN ALFA |
Thyrogen |
Diagnostic for Detection of Thyroid Cancer |
TSH95-0101* |
|
|
|
TLR4 AGONIST IMMUNOMODULATOR |
Not Marketed |
Food Allergy |
TDR14287 |
NA |
||
TOFOGLIFLOZIN |
TOFOGLIFLOZIN |
Diabetes Mellitus Type 2 |
TOFOGL07061 |
NA |
||
TRIAMCINOLONE ACETONIDE |
Nasacort AQ |
Rhinitis |
TRICA_L_00872 |
RhiCNANI |
||
TRIAMCINOLONE ACETONIDE |
Nasacort |
Rhinitis Allergic |
TRICAL07830 |
NASANIF |
|
|
TRIAMCINOLONE ACETONIDE |
Nasacort AQ |
Rhinitis Allergic |
TRICA_L_04286 |
NA |
||
TRIAMCINOLONE ACETONIDE |
Nasacort AQ |
Allergic Rhinitis |
XRG5029C_1000 |
NA |
NA |
|
TRIAMCINOLONE ACETONIDE |
Nasacort AQ |
Allergic Rhinitis |
XRG5029C_3502 |
NA |
||
TRIAMCINOLONE ACETONIDE |
Nasacort AQ |
Rhinitis Allergic |
XRG5029C_3503 |
PAR |
||
TRIAMCINOLONE ACETONIDE |
Nasacort AQ |
Allergic Rhinitis |
XRG5029C_4002 |
NA |
NA |
|
TRIAMCINOLONE ACETONIDE |
Nasacort AQ |
Allergic Rhinitis |
XRG5029C_4004 |
SMART |
NA |
|
TRIAMCINOLONE ACETONIDE |
Nasacort AQ |
Allergic Rhinitis |
XRG5029C_4005 |
NA |
NA |
|
TRIAMCINOLONE ACETONIDE |
Nasacort AQ |
Allergic Rhinitis |
XRG5029C_4006 |
NA |
NA |
|
TRIAMCINOLONE ACETONIDE |
Nasacort AQ |
Allergic Rhinitis |
XRG5029C_4007 |
NA |
NA |
|
TRKA INHIBITOR |
Not marketed |
Osteoarthritis |
TDU13828 / ACT13830 |
NA |
||
TRPV3 ANTAGONIST |
Not marketed |
Neuropathic pain |
ACT11917 |
ALCHEMILLA |
References:
*These study results were previously posted on GenzymeClinicalResearch.com
**This link replaces the same summary that was previously posted